26 Apr 2017 --- Denmark-based biotechnology company Novozymes has reported overall positive Q1 results with a 3% organic sales growth mainly driven by food & beverages and bioenergy. The company reports that sales and earnings are on track with this “good start to 2017” which has also seen solid progress on Novozymes strategic priorities.